<DOC>
	<DOC>NCT02280473</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of a new eye drop formulation in patients with dry eye disease.</brief_summary>
	<brief_title>A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Carboxymethylcellulose Sodium</mesh_term>
	<criteria>Current use of an artificial tear product Visual acuity of at least 20/32 (while wearing glasses, if necessary). Use of contact lenses in the last 3 months, or anticipated use of contact lenses during the study Cataract surgery, laserassisted in situ keratomileusis [LASIK], or photorefractive keratectomy, within the last 6 months Current eye infection or inflammation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>